Advanced Search
Contact | Corporate | Help

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Carcinoma, Small Cell Lung
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: irinotecan
  • Drug: carboplatin
  • Drug: bevacizumab
  • Procedure: Radiation Therapy
Enrollment:
55

Additional information about NCT00308529.


SourceSolution © 2008-2012